EBIT: Income before interest and taxes.
Nutra Pharma Corp. (NPHC) had EBIT of $-0.47M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.05M |
|
$-0.49M |
|
$0.07M |
|
$-0.01M |
|
$0.52M |
|
$-0.47M |
|
$-0.02M |
|
$-0.49M |
|
$-0.49M |
|
$-0.49M |
|
$-0.49M |
|
$-0.49M |
|
$-0.49M |
|
|
EBIT |
$-0.47M |
$-0.36M |
|
7.78B |
|
7.78B |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$0.46M |
|
$0.03M |
|
$0.12M |
|
$0.58M |
|
$17.27M |
|
$0.14M |
|
$0.14M |
|
$17.41M |
|
$-16.84M |
|
$-16.83M |
|
$-16.83M |
|
7.10B |
|
| Cash Flow Statement Financials | |
$-1.16M |
|
$-0.05M |
|
$1.19M |
|
$0.04M |
|
$0.01M |
|
$-0.02M |
|
$0.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.03 |
|
-- |
|
-- |
|
-0.01 |
|
-0.58 |
|
-22.02% |
|
-861.75% |
|
-861.75% |
|
-- |
|
-903.57% |
|
-903.57% |
|
$-1.19M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
3.38 |
|
0.14 |
|
624.13 |
|
2.90% |
|
2.90% |
|
-83.57% |
|
2.93% |
|
$-0.00 |
|
$-0.00 |
|
$-0.00 |
|